NANOS1 and cancer: Our bioinformatic analysis of publicly available expression datasets for cancer (TCGA) and normal tissues (GTEx) showed that NANOS1 is overexpressed in a variety of human cancers, including brain, kidney, liver, lung, ovary, pancreas, skin, thyroid gland uterus, and testis cancers (Figure 2 and Figure 3A).